A novel computational approach for drug repurposing using systems biology
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel computational approach for drug repurposing using systems biology
Authors
Keywords
-
Journal
BIOINFORMATICS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-03-09
DOI
10.1093/bioinformatics/bty133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry
- (2017) Oliver Gautschi et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines
- (2017) Xin Jin et al. Oncology Letters
- Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis
- (2017) Han-Shui Hsu et al. Scientific Reports
- IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
- (2016) Sarah L. Carter et al. BMC CANCER
- Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study
- (2016) Charlotte Skriver et al. CANCER CAUSES & CONTROL
- Deoxypodophyllotoxin triggers parthanatos in glioma cells via induction of excessive ROS
- (2016) Diandong Ma et al. CANCER LETTERS
- Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines
- (2016) Zu-Yau Lin et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- New dimension of glucocorticoids in cancer treatment
- (2016) Kai-Ti Lin et al. STEROIDS
- Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
- (2016) Paul F Mercer et al. THORAX
- Anticancer effect of deoxypodophyllotoxin induces apoptosis of human prostate cancer cells
- (2016) Sheng Hu et al. Oncology Letters
- Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
- (2015) Dayle Rundle-Thiele et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy
- (2015) JAE YEON CHOI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer
- (2015) Peng Yuan et al. MEDICINE
- Colchicine Significantly Reduces Incident Cancer in Gout Male Patients
- (2015) Ming-Chun Kuo et al. MEDICINE
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Refining the treatment of NSCLC according to histological and molecular subtypes
- (2015) Anish Thomas et al. Nature Reviews Clinical Oncology
- Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
- (2015) Sylvie Maubant et al. PLoS One
- Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells
- (2014) Sami Benzina et al. Anti-Cancer Agents in Medicinal Chemistry
- The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: An in vitro study
- (2014) Soha Namazi et al. BIOMEDICINE & PHARMACOTHERAPY
- Global Gene Repression by the Steroid Receptor Coactivator SRC-1 Promotes Oncogenesis
- (2014) C. A. Walsh et al. CANCER RESEARCH
- Chitinase 3-Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis
- (2014) Y. Zhou et al. Science Translational Medicine
- Inhibition of Transglutaminase 2, a Novel Target for Pulmonary Fibrosis, by Two Small Electrophilic Molecules
- (2013) Keith C. Olsen et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Exposure-Response (Safety) Analysis to Identify Linifanib Dose for a Phase III Study in Patients With Hepatocellular Carcinoma
- (2013) Yi-Lin Chiu et al. CLINICAL THERAPEUTICS
- Synergistic Inhibition of Angiogenesis by Artesunate and CaptoprilIn VitroandIn Vivo
- (2013) Benjamin Krusche et al. Evidence-based Complementary and Alternative Medicine
- Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity
- (2013) Sudipan Karmakar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
- (2013) Zhe Rong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Therapeutic efficacy of Sunitinib and other broad spectrum receptor tyrosine kinase inhibitors (RTKI) in bleomycin-induced pulmonary fibrosis
- (2013) D Knoerzer et al. Journal of Inflammation-London
- PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition
- (2013) Enrico Conte et al. LABORATORY INVESTIGATION
- Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions
- (2013) J. F. Gainor et al. ONCOLOGIST
- Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1
- (2013) MINGQIANG REN et al. ONCOLOGY REPORTS
- TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
- (2013) Virginie Maire et al. PLoS One
- A Synthetic Podophyllotoxin Derivative Exerts Anti-Cancer Effects by Inducing Mitotic Arrest and Pro-Apoptotic ER Stress in Lung Cancer Preclinical Models
- (2013) Jia-Yang Chen et al. PLoS One
- Mefloquine induces cell death in prostate cancer cells and provides a potential novel treatment strategy in vivo
- (2013) KUN-HUANG YAN et al. Oncology Letters
- Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
- (2013) Poornima Bhat-Nakshatri et al. Scientific Reports
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- (2013) Mariel Núñez et al. BMC Pharmacology & Toxicology
- Matrix Metalloproteinase-2 and -9 in Glioblastoma: A Trio of Old Drugs—Captopril, Disulfiram and Nelfinavir—Are Inhibitors with Potential as Adjunctive Treatments in Glioblastoma
- (2012) Richard E. Kast et al. ARCHIVES OF MEDICAL RESEARCH
- Tyrosine kinase signaling in fibrotic disorders
- (2012) Christian Beyer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent
- (2012) Natasha Sharma et al. CANCER LETTERS
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer
- (2012) V. Maire et al. CANCER RESEARCH
- Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells
- (2012) Tamami Yasukagawa et al. FEBS LETTERS
- Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome
- (2012) A. Chase et al. HAEMATOLOGICA
- Interplay of reactive oxygen species, intracellular Ca2+and mitochondrial homeostasis in the apoptosis of prostate cancer cells by deoxypodophyllotoxin
- (2012) Kwang-Youn Kim et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- RET Fusion Genes in Non–Small-Cell Lung Cancer
- (2012) Bo H. Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
- (2012) Kevin S. Choe et al. JOURNAL OF CLINICAL ONCOLOGY
- The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis
- (2012) Simon Ekman et al. Journal of Thoracic Oncology
- Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia
- (2012) Eunice S. Wang et al. LEUKEMIA & LYMPHOMA
- Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells
- (2012) Guang Yan et al. MOLECULAR CARCINOGENESIS
- MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation
- (2011) Satish K. Madala et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Exploiting drug-disease relationships for computational drug repositioning
- (2011) J. T. Dudley et al. BRIEFINGS IN BIOINFORMATICS
- Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
- (2011) Ayca Gucalp et al. Clinical Breast Cancer
- Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases
- (2011) Silvia Novello et al. Journal of Thoracic Oncology
- Mining for therapeutic gold
- (2011) Francis S. Collins NATURE REVIEWS DRUG DISCOVERY
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA
- (2011) G Paroni et al. ONCOGENE
- Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice
- (2011) Chin Kook Rhee et al. RESPIRATION
- Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
- (2011) M. Sirota et al. Science Translational Medicine
- Recent developments in prostate cancer biomarker research: therapeutic implications
- (2010) Sujitra Detchokul et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Phase II Trial of Gefitinib and Everolimus in Advanced Non-small Cell Lung Cancer
- (2010) Katharine A. Price et al. Journal of Thoracic Oncology
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Targeting non-malignant disorders with tyrosine kinase inhibitors
- (2010) Friedrich Grimminger et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
- (2009) J.-C. Soria et al. ANNALS OF ONCOLOGY
- A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
- (2009) Primo N. Lara et al. ANTI-CANCER DRUGS
- Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents
- (2009) AE Leitch et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Targeting cancer with phosphodiesterase inhibitors
- (2009) Rajkumar Savai et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effect of Sirolimus on Prostate-Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer
- (2008) K. Chamie et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Glibenclamide exerts an antitumor activity through reactive oxygen species–c-jun NH(2)-terminal kinase pathway in human gastric cancer cell line MGC-803
- (2008) Xia Qian et al. BIOCHEMICAL PHARMACOLOGY
- Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy
- (2008) Bruce D Keith BMC CANCER
- Pilot Study of Rapamycin in Patients with Hormone-Refractory Prostate Cancer
- (2008) Robert J. Amato et al. Clinical Genitourinary Cancer
- The Potential Role of mTOR Inhibitors in Non-Small Cell Lung Cancer
- (2008) C. Gridelli et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now